Fintel reports that on January 27, 2026, TD Cowen initiated coverage of SI-BONE (NasdaqGM:SIBN) with a Buy recommendation.
Analyst Price Forecast Suggests 54.06% Upside
As of January 14, 2026, the average one-year price target for SI-BONE is $26.41/share. The forecasts range from a low of $23.23 to a high of $33.60. The average price target represents an increase of 54.06% from its latest reported closing price of $17.14 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for SI-BONE is 192MM, a decrease of 1.01%. The projected annual non-GAAP EPS is -1.70.
What is the Fund Sentiment?
There are 343 funds or institutions reporting positions in SI-BONE. This is an decrease of 25 owner(s) or 6.79% in the last quarter. Average portfolio weight of all funds dedicated to SIBN is 0.13%, an increase of 10.40%. Total shares owned by institutions increased in the last three months by 1.64% to 52,170K shares. 
The put/call ratio of SIBN is 0.09, indicating a bullish outlook.
What are Other Shareholders Doing?
American Century Companies holds 2,838K shares representing 6.54% ownership of the company. In its prior filing, the firm reported owning 2,316K shares , representing an increase of 18.38%. The firm decreased its portfolio allocation in SIBN by 10.26% over the last quarter.
Brown Advisory holds 2,773K shares representing 6.39% ownership of the company. In its prior filing, the firm reported owning 2,913K shares , representing a decrease of 5.04%. The firm decreased its portfolio allocation in SIBN by 70.23% over the last quarter.
Orbimed Advisors holds 2,579K shares representing 5.94% ownership of the company. No change in the last quarter.
Champlain Investment Partners holds 2,109K shares representing 4.86% ownership of the company. In its prior filing, the firm reported owning 2,140K shares , representing a decrease of 1.48%. The firm decreased its portfolio allocation in SIBN by 16.74% over the last quarter.
First Light Asset Management holds 1,918K shares representing 4.42% ownership of the company. In its prior filing, the firm reported owning 1,751K shares , representing an increase of 8.70%. The firm decreased its portfolio allocation in SIBN by 37.71% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
